ANDREW MCDOWELL: Open Payments
NPI 1376947432 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,649 in 165 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $410 · 2025 $3,649
Food & beverage: $3,572Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $581 |
| Ardelyx, Inc. | 22 | $487 |
| Janssen Biotech, Inc. | 16 | $397 |
| Madrigal Pharmaceuticals | 10 | $367 |
| Gilead Sciences, Inc. | 21 | $343 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $305 |
| Phathom Pharmaceuticals, Inc. | 15 | $301 |
| Lilly USA, LLC | 12 | $188 |
| Celltrion USA Inc. | 5 | $138 |
| Intercept Pharmaceuticals, Inc. | 4 | $102 |
Products named: IBSRELA, TREMFYA, REZDIFFRA, VOQUEZNA, CREON, OMVOH, ENTYVIO, LINZESS.
Industry payments across CT — which companies pay providers there.
